Pharmaceutical Preformulation and Formulation: a Practical Guide from Candidate Drug Selection to Commercial Dosage Form - 2nd ed. (2009) Practical and evidence based, British National Formulary (BNF) is the only drug formulary in the world that is both independent, and has rigorous, accredited content creation processes. As an example, here's a reference for the whole print BNF in Harvard format (remember, though, that you will probably be referencing a specific entry): In general, drug and product names should be written in full. Unofficial abbreviations should not be used as they may be misinterpreted. Non-proprietary titles

An integral part of the UK’s healthcare infrastructure and relied on by health professionals who prescribe, dispense, and administer medicines globally. Containing guidance on best practice in prescribing, as well as legal and ethical considerations, BNF supports safe and effective decision-making at the point of care.In the body of your text, an indication of where the information for a specific sentence or quote comes from. Depending on which referencing style you use, this might be the name of the author of the information source and the year it was written, or it might be a number. For example, Harvard uses author and date, whereas Vancouver uses a number system. Reference list Physicochemical Principles of Pharmacy in Manufacture, Formulation and Clinical Use - 6th ed. (2016) Therapeutic equivalence g Biosimal drugs should be considered therapeutically equivalent to the original biological drug within their permitted designations. h Biosimal drugs are generally licensed for all indications of biological drug development, but are subject to evidence submitted to the EMA for approval and must be scientifically substantiated by proven or extrapolated agreement. Prescribing and administering The choice of prescribing a biosimal drug or a drug of biological origin is up to the physician in consultation with the patient. g Biological drugs (including biosimal drugs) must be prescribed and labeled to prevent prescription. Automatic label exchange at the point of delivery is not suitable for biological medicines. Shortened to subtitles

Biologics, Biosimilars and Biobetters: An Introduction for Pharmacists, Physicians and other Health Practitioners(2021) Pre-treatment screening advice on genetic testing for aminoglycoside exposure posing risk to hearing Livtencity® [maribavir] for cytomegalovirus disease in recipients of haematopoietic stem cell transplant or solid organ transplant Pharmaceutical Excipients: Properties, Functionality and Applications in Research and Industry (2017)Never Incidents Never Incidents are serious and preventable medical errors where preventive measures must be taken to stop their occurrence. National Institute for Health and Care Excellence (2020) Acute coronary syndromes. NG185. Available at:https://www.nice.org.uk/guidance/ng185(Accessed: 7 December 2020).